tiprankstipranks
BeOne Medicines Ltd (HK:6160)
:6160
Hong Kong Market
6160
BeOne Medicines Ltd
RESEARCH TOOLSreports

BeOne Medicines Ltd (6160) Ratios

22 Followers

BeOne Medicines Ltd Ratios

HK:6160's free cash flow for Q4 2025 was $0.88. For the 2025 fiscal year, HK:6160's free cash flow was decreased by $ and operating cash flow was $0.12. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 3.41 3.41 1.80 2.32 3.55
Quick Ratio
 3.08 3.08 1.58 2.09 3.35
Cash Ratio
 2.51 2.51 1.19 1.75 2.63
Solvency Ratio
 0.11 0.11 -0.18 -0.35 -0.97
Operating Cash Flow Ratio
 0.62 0.62 -0.06 -0.64 -1.02
Short-Term Operating Cash Flow Coverage
 19.77 19.71 -0.17 -1.68 -4.55
Net Current Asset Value
$ 2.39B$ 2.39B$ 1.40B$ 1.94B$ 3.21B
Leverage Ratios
Debt-to-Assets Ratio
 0.13 0.13 0.18 0.16 0.09
Debt-to-Equity Ratio
 0.25 0.25 0.32 0.26 0.14
Debt-to-Capital Ratio
 0.20 0.20 0.24 0.21 0.12
Long-Term Debt-to-Capital Ratio
 0.18 0.29 0.05 0.05 0.05
Financial Leverage Ratio
 1.89 1.89 1.78 1.64 1.46
Debt Service Coverage Ratio
 5.89 3.98 -0.60 -1.71 -5.37
Interest Coverage Ratio
 21.74 7.68 0.00 0.00 0.00
Debt to Market Cap
 0.03 0.06 0.05 0.05 0.02
Interest Debt Per Share
 0.77 0.81 0.79 0.69 0.45
Net Debt to EBITDA
 -5.94 -5.93 3.90 2.00 1.90
Profitability Margins
Gross Profit Margin
86.91%85.28%84.41%84.55%-36.09%
EBIT Margin
8.37%8.37%-14.91%-49.12%-126.40%
EBITDA Margin
11.02%11.02%-10.40%-45.55%-121.71%
Operating Profit Margin
8.37%8.37%-14.91%-49.12%-126.40%
Pretax Profit Margin
7.80%7.80%-13.99%-33.59%-138.50%
Net Profit Margin
5.37%5.37%-16.92%-35.86%-141.52%
Continuous Operations Profit Margin
5.37%5.37%-16.92%-35.86%-141.52%
Net Income Per EBT
68.84%68.83%120.97%106.77%102.18%
EBT Per EBIT
93.23%93.23%93.81%68.38%109.58%
Return on Assets (ROA)
3.49%3.49%-10.89%-15.19%-31.41%
Return on Equity (ROE)
7.28%6.59%-19.35%-24.93%-45.71%
Return on Capital Employed (ROCE)
6.98%6.99%-15.33%-30.23%-36.44%
Return on Invested Capital (ROIC)
4.75%4.76%-12.42%-25.67%-34.00%
Return on Tangible Assets
3.51%3.52%-11.13%-15.34%-33.06%
Earnings Yield
0.83%0.88%-3.35%-4.80%-8.70%
Efficiency Ratios
Receivables Turnover
 6.02 6.03 5.37 6.21 7.12
Payables Turnover
 1.46 1.64 1.47 1.21 6.54
Inventory Turnover
 1.15 1.30 1.20 0.91 6.82
Fixed Asset Turnover
 2.98 2.99 2.30 1.73 1.67
Asset Turnover
 0.65 0.65 0.64 0.42 0.22
Working Capital Turnover Ratio
 1.39 1.73 1.83 0.80 0.29
Cash Conversion Cycle
 128.01 120.34 123.22 155.81 48.94
Days of Sales Outstanding
 60.59 60.49 67.93 58.77 51.29
Days of Inventory Outstanding
 317.40 281.79 304.11 399.78 53.48
Days of Payables Outstanding
 249.98 221.94 248.82 302.74 55.84
Operating Cycle
 377.99 342.28 372.04 458.55 104.78
Cash Flow Ratios
Operating Cash Flow Per Share
 0.79 0.80 -0.10 -0.85 -1.12
Free Cash Flow Per Share
 0.60 0.67 -0.49 -1.29 -1.47
CapEx Per Share
 0.19 0.13 0.39 0.44 0.24
Free Cash Flow to Operating Cash Flow
 0.76 0.84 4.76 1.52 1.31
Dividend Paid and CapEx Coverage Ratio
 4.24 6.07 -0.27 -1.94 -4.60
Capital Expenditure Coverage Ratio
 4.24 6.07 -0.27 -1.94 -4.60
Operating Cash Flow Coverage Ratio
 1.04 1.03 -0.13 -1.24 -2.51
Operating Cash Flow to Sales Ratio
 0.21 0.21 -0.04 -0.47 -1.06
Free Cash Flow Yield
2.40%2.89%-3.48%-9.54%-8.53%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 120.36 113.64 -29.83 -20.84 -11.49
Price-to-Sales (P/S) Ratio
 6.75 6.10 5.05 7.47 16.27
Price-to-Book (P/B) Ratio
 7.92 7.49 5.77 5.20 5.25
Price-to-Free Cash Flow (P/FCF) Ratio
 41.63 34.63 -28.72 -10.48 -11.72
Price-to-Operating Cash Flow Ratio
 30.49 28.92 -136.77 -15.88 -15.39
Price-to-Earnings Growth (PEG) Ratio
 0.37 -0.80 1.08 0.37 -0.42
Price-to-Fair Value
 7.92 7.49 5.77 5.20 5.25
Enterprise Value Multiple
 55.28 49.45 -44.61 -14.41 -11.47
Enterprise Value
 32.54B 29.16B 17.69B 16.14B 19.76B
EV to EBITDA
 55.28 49.45 -44.61 -14.41 -11.47
EV to Sales
 6.09 5.45 4.64 6.56 13.96
EV to Free Cash Flow
 37.59 30.92 -26.41 -9.20 -10.05
EV to Operating Cash Flow
 28.73 25.82 -125.76 -13.94 -13.20
Tangible Book Value Per Share
 3.01 3.05 2.34 2.56 3.03
Shareholders’ Equity Per Share
 3.03 3.08 2.43 2.61 3.27
Tax and Other Ratios
Effective Tax Rate
 0.31 0.31 -0.21 -0.07 -0.02
Revenue Per Share
 3.71 3.77 2.78 1.81 1.06
Net Income Per Share
 0.20 0.20 -0.47 -0.65 -1.49
Tax Burden
 0.69 0.69 1.21 1.07 1.02
Interest Burden
 0.93 0.93 0.94 0.68 1.10
Research & Development to Revenue
 0.40 0.39 0.51 0.72 1.16
SG&A to Revenue
 0.39 0.38 0.48 0.00 0.00
Stock-Based Compensation to Revenue
 0.07 0.00 0.12 0.15 0.21
Income Quality
 3.95 3.93 0.22 1.31 0.75
Currency in USD